Zhejiang Chimin Pharm Co Ltd - Asset Resilience Ratio
Zhejiang Chimin Pharm Co Ltd (603222) has an Asset Resilience Ratio of 4.12% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Zhejiang Chimin Pharm Co Ltd (603222) strategic investment index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2023)
This chart shows how Zhejiang Chimin Pharm Co Ltd's Asset Resilience Ratio has changed over time. See Zhejiang Chimin Pharm Co Ltd net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Chimin Pharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Zhejiang Chimin Pharm Co Ltd (603222) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥100.00 Million | 4.12% |
| Total Liquid Assets | CN¥100.00 Million | 4.12% |
Asset Resilience Insights
- Limited Liquidity: Zhejiang Chimin Pharm Co Ltd maintains only 4.12% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Chimin Pharm Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhejiang Chimin Pharm Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Touchstone International Medical Science Co Ltd
SHG:688013 |
Medical Instruments & Supplies | 37.86% |
|
Formosa Optical Technology Co Ltd
TWO:5312 |
Medical Instruments & Supplies | 46.32% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.29% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
Annual Asset Resilience Ratio for Zhejiang Chimin Pharm Co Ltd (2018–2023)
The table below shows the annual Asset Resilience Ratio data for Zhejiang Chimin Pharm Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 4.44% | CN¥110.00 Million ≈ $16.10 Million |
CN¥2.48 Billion ≈ $362.90 Million |
+1.23pp |
| 2021-12-31 | 3.20% | CN¥77.68 Million ≈ $11.37 Million |
CN¥2.43 Billion ≈ $354.86 Million |
-2.41pp |
| 2020-12-31 | 5.61% | CN¥128.59 Million ≈ $18.82 Million |
CN¥2.29 Billion ≈ $335.39 Million |
-0.84pp |
| 2019-12-31 | 6.45% | CN¥134.41 Million ≈ $19.67 Million |
CN¥2.08 Billion ≈ $305.03 Million |
+0.36pp |
| 2018-12-31 | 6.09% | CN¥129.47 Million ≈ $18.95 Million |
CN¥2.12 Billion ≈ $310.93 Million |
-- |
About Zhejiang Chimin Pharm Co Ltd
Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-tube double-valve, single-tube single-valve, and single-tube double-valve soft bags; plastic bottles; and other packaging forms. It also offers medical instruments, in… Read more